Concourse Financial Group Securities’s Cantel Medical Corporation CMD Stock Holding History

Concourse Financial Group Securities’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-501	Closed	-$18.7K	–	2331
2020 Q1	$18K	Buy	501 +66	+15%	+$3.75K	﹤0.01%	1287
2019 Q4	$31K	Buy	435 +208	+92%	+$15.1K	﹤0.01%	1122
2019 Q3	$17K	Sell	227 -83	-27%	-$7.04K	﹤0.01%	1015
2019 Q2	$25K	Buy	310 +11	+4%	+$773	﹤0.01%	1173
2019 Q1	$20K	Buy	299 +39	+15%	+$2.95K	﹤0.01%	1280
2018 Q4	$19K	Buy	260 +64	+33%	+$5.28K	﹤0.01%	1187
2018 Q3	$18K	Buy	+196	New	+$18.7K	0.01%	904

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Concourse Financial Group Securities's CMD Position: Q2 2020 in Review

Concourse Financial Group Securities sold out of Cantel Medical Corporation (CMD) in Q2 2020, closing a stake of 501 shares — an estimated $18.7K sold.

Concourse Financial Group Securities first reported a position in CMD in Q3 2018 and held it in 7 quarters. The position peaked at $31K in Q4 2019. 210 funds tracked by Wall St. Rank hold CMD as of Q2 2020.

Concourse Financial Group Securities reported no remaining Cantel Medical Corporation position as of Q2 2020 after selling out during the quarter.
Concourse Financial Group Securities sold 501 Cantel Medical Corporation shares in Q2 2020, an estimated $18.7K.
Concourse Financial Group Securities first reported a position in Cantel Medical Corporation in Q3 2018 and held it in 7 quarters.
Concourse Financial Group Securities's Cantel Medical Corporation position peaked at $31K in Q4 2019.
210 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2020.

Based on Concourse Financial Group Securities's 13F filing for Q2 2020, filed 13 Aug 2020.